Skip to main content

Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.38
+0.24 (0.10%)
AAPL  273.81
+1.45 (0.53%)
AMD  215.04
+0.14 (0.07%)
BAC  56.25
+0.28 (0.50%)
GOOG  315.67
-0.01 (-0.00%)
META  667.55
+2.61 (0.39%)
MSFT  488.02
+1.17 (0.24%)
NVDA  188.61
-0.60 (-0.32%)
ORCL  197.49
+2.15 (1.10%)
TSLA  485.40
-0.16 (-0.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.